Nject Investments Limited

	Page
Balance Sheet	1
Notes to the Financial Statements	2

Registered number: 16000282

		31 October 2025
	Notes	£	£
FIXED ASSETS
Investments	4		786,645

			786,645
CURRENT ASSETS
Investments	5	470,000
Cash at bank and in hand		21,120

		491,120
NET CURRENT ASSETS (LIABILITIES)			491,120

TOTAL ASSETS LESS CURRENT LIABILITIES			1,277,765

NET ASSETS			1,277,765

CAPITAL AND RESERVES
Called up share capital	6		3
Profit and Loss Account			1,277,762

SHAREHOLDERS' FUNDS			1,277,765

For the period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Neil Avery

Director

07/07/2026

The notes on page 2 form part of these financial statements.

1. General Information

Nject Investments Limited is a private company, limited by shares, incorporated in England & Wales, registered number 16000282 . The registered office is Tate House, Watermark Way, Hertford, England, SG13 7TZ.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

3. Average Number of Employees

Average number of employees, including directors, during the period was: 1

4. Investments

	Other
	£
Cost or Valuation
As at 7 October 2024	-
Additions	786,645

As at 31 October 2025	786,645

Provision
As at 7 October 2024	-

As at 31 October 2025	-

Net Book Value
As at 31 October 2025	786,645

As at 7 October 2024	-

5. Current Asset Investments

	31 October 2025
	£
Listed investments	470,000

6. Share Capital

	31 October 2025
	£
Allotted, Called up and fully paid	3